Caner Saygin, M.D.

77% fewer Medicare Part D claims than the average hematology & oncology physician in 2024

205 Medicare Part D claims for 19 beneficiaries, against an average of 877 among the 10,784 providers of this specialty who prescribed in Part D. Brand-name drugs were 29% of claims.

Most prescribed

1. Acyclovir31 claims
2. Sulfamethoxazole-Trimethoprim22 claims
3. Venclexta21 claims
4. Prochlorperazine Maleate17 claims
5. Idhifa13 claims
6. Jaypirca12 claims

Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.

The MIPS final score for 2023 (Medicare payment program): 97.7 of 100

The Merit-based Incentive Payment System score is reported for this clinician. Four categories are weighted into the final score; the average among 454,083 clinicians with a measured score was 83.5.

Source: CMS Quality Payment Program, MIPS performance year 2023; category weights for 2023 (qpp.cms.gov).

2 hospitals and group practices

1. The University OF Chicago Medical CenterChicago, IL · Acute Care Hospitals4 of 5 stars
2. University OF ChicagoChicago, IL

Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through); hospitals matched to CMS Hospital General Information (Care Compare) (data.cms.gov). Star ratings are CMS hospital ratings, not ratings of this provider.